LORETO
VIDAUR TELLO
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (11)
2022
-
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21
2021
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Science immunology, Vol. 6, Núm. 62
2017
-
Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case–control study
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 1, pp. 123-130
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2013
-
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy
Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326
-
Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia
Intensive Care Medicine, Vol. 39, Núm. 4, pp. 693-702
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Pandemic and post-pandemic Influenza A (H1N1) infection in critically ill patients
Critical Care, Vol. 15, Núm. 6
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85
2009
-
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain
Critical Care, Vol. 13, Núm. 5